Tag: Patient risks

FDA announces Class 1 recalls for laryngoscopes, ventilators

Editor's Note Recalls of certain devices and instruction updates for others prompted the US Food and Drug Administration (FDA) to issue Class 1 recalls—the most severe category indicating risk of serious injury or death—for two groups of products: Medtronic’s McGrath MAC and MAC EMS Video Laryngoscopes and Breas Medical’s Vivo…

Read More

By: Matt Danford
September 6, 2024
Share

How perioperative staff can combat human trafficking—Part 1

Human trafficking (HT) is a global public health crisis and one of the fastest growing criminal enterprises that grosses hundreds of billions of dollars annually, all of which are tax-free profits made off the sale of human cargo. And yet, research shows the problem is poorly understood or recognized among…

Read More

By: Francine Bono-Neri, PhD, RN, APRN, PNP
August 28, 2024
Share

Antibiotics gaining acceptance as potential alternative to pediatric appendectomy

Washington Post logo

Editor's Note Evidence is mounting for the use of antibiotics as a valid alternative to surgery for acute appendicitis, including in pediatric cases, the Washington Post reported August 17. The article details how this treatment—described as a “dark secret” by one expert testifying to its use in the 1950s, prior…

Read More

By: Matt Danford
August 21, 2024
Share

Study: Uterus transplant associated with high birth rates, but significant risks

JAMA (healthcare publication) Network logo

Editor's Note Uterus transplants are feasible, but the procedure is associated with considerable risks for both patient and organ donor, according to a study published August 15 in JAMA.   Conducted at a large US tertiary care center, the study involved 20 women with absolute uterine-factor infertility—a condition that prevents…

Read More

By: Matt Danford
August 16, 2024
Share

FDA announces Class 1 recalls for nerve monitoring system, ambulatory infusion pumps

Editor's Note The US Food and Drug Administration (FDA) designated recalls of Medtronic’s NIM Vital Nerve Monitoring System and Smith Medical’s CADD-Solis Ambulatory Infusion Pumps as Class 1, the most severe category indicating serious risk of injury or death. Reports of false negative responses prompted Medtronic to recall the nerve…

Read More

By: Matt Danford
August 7, 2024
Share

Study: Spinal fusion failure more likely for diabetic patients

Editor's Note Lumbar spinal fusion procedures are significantly more likely to fail in individuals with diabetes, according researchers at The University of Toledo. According to a July 9 EurekAlert! report on the study, published in JBMR Plus, diabetic patients are already known to have a higher risk of infection from…

Read More

By: Matt Danford
August 6, 2024
Share

Study on pre, postop opioid use reveals improvements needed for managing young patients

Editor's Note Many youths continue to take opioids months after undergoing surgery, according to a recent multi-institutional study published in JAMA Network. Medical Xpress covered the news July 11. Conducted by researchers from CHOP, Massachusetts General Hospital, University of Pennsylvania, and Stanford Medicine, the study found 1 in 6 youths…

Read More

By: Matt Danford
July 30, 2024
Share

Study: Intraoperative DEX infusions effectively manage diabetes in cardiac surgery patients

Editor's Note Intraoperative infusion of dexmedetomidine (DEX) could help improve glycemic control and reduce insulin requirements in diabetic patients undergoing cardiac surgery, according to a July 25 article in Medical Dialogues. The article focuses on a prospective observational study published in the journal Annals of Cardiac Anesthesia. The study included…

Read More

By: Matt Danford
July 29, 2024
Share

FDA announces Class 1 recalls of ventilator, eye injection kits

Editor's Note The US Food & Drug Administration has designated recalls of Baxter’s Life2000 Ventilator and the I-Pack Injection Kit from Bausch + Lomb and subsidiary Synergetics Inc. as Class 1, the most severe category indicating serious risk of injury or death. According to FDA’s July 15 announcement, the ventilator…

Read More

By: Matt Danford
July 16, 2024
Share

Study: Gastric bypass offers cardiovascular benefits regardless of weight loss

Editor's Note Roux-en-Y gastric bypass (RYGB) reduces cardiovascular risk factors independent of calorie restriction and weight loss, according to a recent study published in JAMA Surgery. News-Medical.Net reported on the study July 4. Bariatric surgery, particularly RYGB, is more effective than non-surgical treatments for significant weight reduction and lowering cardiovascular…

Read More

By: Matt Danford
July 15, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat